August 2023 Newsletter

August 29, 2023
Download as PDF


Please join ACT on Thursday, September 14th for our fall fundraiser event, Growing Hope. Along with award winning wine, enjoy a charcuterie appetizer spread and live jazz music overlooking the north shores of Lake Waconia and the stunning Sovereign Estates grounds. A mouth-watering Italian dinner buffet with vegetarian and gluten free options will be served.

Researchers are continuing to uncover the connections between the health and diversity of our gut microbes in multiple areas of our health. ACT partners with world leaders in their field to investigate and develop targeted microbiota therapies. The research team will be available to answer questions during the social hour, and present recent findings during the event program.

Register for Growing Hope


Interested in actively enjoying the outdoors as the fall colors emerge while supporting a cause? Consider joining ACT’s Twin Cities Marathon or 10-Mile team. This year is the 25th anniversary of the ten-miler, and the only way to join this sold-out event is through a charity team. Runners on ACT’s team receive a complimentary race shirt. The deadline to register is quickly approaching on September 25th, snag your spot today! Learn more about ACT’s race team and register today!

Join or Support ACT's Race Team


ACT is hosting a complimentary showing and panel discussion for the Minnesota premiere of the documentary Designer $hit on October 19th at the Trylon Cinema. Director Saffron Cassady has suffered from Ulcerative Colitis for nearly a decade. Follow Saffron’s personal journey to find respite and a cure from this terrible disease.

Post-screening, ACT will host a panel discussion featuring:

  • Dr. Alexander Khoruts, Director of the University of Minnesota Microbiota Therapeutics Program
  • Dr. Beth Adams, parent of an Ulcerative Colitis patient
  • Amanda Kabage, Research Program Manager and Regulatory Specialist at the University of Minnesota Microbiota Therapeutics Program and Ulcerative Colitis patient
  • Peter Westerhaus, Achieving Cures Together founder and Ulcerative Colitis patient

Reserve Your Seat

2023 Research Update

Achieving Cures Tother is on a mission to save lives by restoring microbial health. Our work is centered on meaningful partnerships. With the Microbiota Therapeutics Program at the University of Minnesota, we continue to treat patients with recurrent C. difficile Infections. To date, we have treated over 2,000 patients with a 98% cure rate. In addition, the microbiota therapies our partners at the University of Minnesota formulate, are provided to clinical trials with academic partners around the country.
Our current research projects include:

  • Autism (Arizona State University)
  • Pitt-Hopkins Disease (Arizona State University)
  • Ulcerative Colitis (University of Minnesota)
  • Advanced Liver Disease (Richmond VA & Virginia Commonwealth University)
  • C. difficile Infections Clinical Treatment Registry (University of Minnesota, Indiana University, Brown University, Harvard University)
  • Complications of Bone Marrow Transplantation (University of Minnesota)
  • Complications of Intensive Chemotherapy for Acute Leukemia (University of Minnesota)
  • Food Allergies (Harvard)
  • Complications of Immunotherapy for Lung Cancer (University of Minnesota, University of Pittsburg & Seattle) Immunotherapy treatments boost the immune system to attack cancer cells, but can result in auto-immune activity where the body also attacks its own cells.
  • Pulmonary Arterial Hypertension (University of Minnesota)
  • Post-Intestinal Microbiota Transplant MEND Diet (University of Minnesota) Researchers are investigating how diet impacts patient success after a microbiota transplant.
  • Post-operative Crohn’s Disease (University of Minnesota)

In addition to our current clinical trials, emerging research projects include:

  • Alopecia Areata (Columbia University) An auto-immune disease that attacks hair follicles and causes hair loss.
  • Congestive Heart Failure (Columbia University)
  • Checkpoint Inhibitor Colitis (University of Minnesota)
  • Children’s Primary Sclerosing Cholangitis (University of Minnesota) A progressive liver disease that can lead to cirrhosis liver failure.
  • Diverticulitis (University of Massachusetts)
  • Multi-Drug Antibiotic Resistance (Emory University)
  • Multiple Sclerosis (University of Chicago)
  • Parkinson’s Disease (Mayo)

Learn directly from some of our partners on the exciting advancements being made in this frontier of medicine.

Dr. Armin Rashidi, M.D., Ph.D., Fred Hutchison Cancer Center Complications with Acute Leukemia & Stem Cell Transplantation

“The patients I take care of and try to improve their outcomes through microbiome therapies are arguably among the most fragile and most immunocompromised patients in medicine.”

Watch Dr. Rashidi's Update

Dr. Byron Vaughn, M.D., M.S., University of Minnesota Ulcerative Colitis and Crohn’s Disease

“The most exciting part of our study was that [Ulcerative Colitis patients] on [Intestinal Microbiota Transplant] capsules had a reduction in their symptoms, compared to people with placebo. The people who received placebo were then given a chance to have the active capsules and when they were on the active capsules, their symptoms got better too. We have a really strong argument that our capsules are clinically effective.”

Watch Dr. Vaughn's Update

Rima Rachid, M.D., Boston Children’s Hospital and Harvard Medical School Food Allergies

In our clinical trial “there was a 60% efficacy response [of reduced reactivity to peanuts] just from one Fecal Microbiota Transplant. It takes about 6 months of oral immunotherapy to reach that level of peanut tolerance.”

Watch Dr. Rachid's Update

Watch all Research Partner Updates

Save Lives by Advancing Microbiota Research

Your partnership makes a life-changing difference, providing hope and healing to suffering patients and their families. Thank you for your support.

Donate Today


This is some text inside of a div block.

What’s a Rich Text element?

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.